当前位置: 首页 > 期刊 > 《医学信息》 > 2019年第6期
编号:13392089
细胞减瘤术联合腹腔热灌注化疗治疗在结直肠癌腹膜转移的临床应用(6)
http://www.100md.com 2019年2月12日 《医学信息》 2019年第6期
     [32]Kwakman R,Schrama AM,van Olmen JP,et al.Clinicopathological Parameters in Patient Selection for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer Metastases:A Meta-analysis[J].Annals of Surgery,2016,263(6):1102.

    [33]Pompiliu P,Kathrin S,Michael G,et al.Benefit of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with isolated peritoneal metastases from colorectal cancer[J].International Journal of Colorectal Disease,2018,33(11):1559-1567.

    [34]Sheshadri DB,Chakravarthy MR.Anaesthetic Considerations in the Perioperative Management of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy[J].Indian Journal of Surgical Oncology,2016,7(2):236-243.

    [35]Mirnezami R,Moran BJ,Harvey K,et al.Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal metastases[J].World Journal of Gastroenterology,2014,20(38):14018-14032.

    [36]Saxena A,Yan TD,Morris DL.A critical evaluation of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis[J].World Journal of Surgery,2009,34(1):70.

    收稿日期:2018-10-25;修回日期:2019-1-5

    編辑/肖婷婷, 百拇医药(梁晋尧 罗诗樵)
上一页1 2 3 4 5 6